ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $243,762 | +10.3% | 11,280 | -1.2% | 0.00% | – |
| Q3 2022 | $221,000 | -1.8% | 11,416 | +0.7% | 0.00% | – |
| Q2 2022 | $225,000 | -30.6% | 11,335 | +4.5% | 0.00% | – |
| Q1 2022 | $324,000 | +37.9% | 10,846 | +7.3% | 0.00% | – |
| Q4 2021 | $235,000 | -19.0% | 10,112 | +9.0% | 0.00% | – |
| Q3 2021 | $290,000 | -10.5% | 9,279 | +0.9% | 0.00% | – |
| Q2 2021 | $324,000 | -23.6% | 9,200 | -23.5% | 0.00% | – |
| Q1 2021 | $424,000 | -40.4% | 12,028 | -36.5% | 0.00% | – |
| Q4 2020 | $711,000 | +214.6% | 18,929 | +172.8% | 0.00% | – |
| Q1 2018 | $226,000 | – | 6,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
| Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
| Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
| BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
| SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
| Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
| Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
| Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
| HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |